DMET-Analyzer: automatic analysis of Affymetrix DMET Data

被引:49
|
作者
Guzzi, Pietro Hiram [1 ]
Agapito, Giuseppe [1 ]
Di Martino, Maria Teresa [2 ,3 ]
Arbitrio, Mariamena [4 ]
Tassone, Pierfrancesco [2 ,3 ]
Tagliaferri, Pierosandro [2 ,3 ]
Cannataro, Mario [1 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy
[2] Magna Graecia Univ Catanzaro, Med Oncol Unit, Catanzaro, Italy
[3] Tommaso Campanella Canc Ctr, Catanzaro, Italy
[4] UOS Pharmacol, Inst Neurol Sci ISN CNR, Catanzaro, Italy
来源
BMC BIOINFORMATICS | 2012年 / 13卷
关键词
SINGLE NUCLEOTIDE POLYMORPHISMS; GENOMIC MEDICINE; BIOINFORMATICS; PHARMACOGENETICS; INFORMATICS; ASSOCIATION;
D O I
10.1186/1471-2105-13-258
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Clinical Bioinformatics is currently growing and is based on the integration of clinical and omics data aiming at the development of personalized medicine. Thus the introduction of novel technologies able to investigate the relationship among clinical states and biological machineries may help the development of this field. For instance the Affymetrix DMET platform (drug metabolism enzymes and transporters) is able to study the relationship among the variation of the genome of patients and drug metabolism, detecting SNPs (Single Nucleotide Polymorphism) on genes related to drug metabolism. This may allow for instance to find genetic variants in patients which present different drug responses, in pharmacogenomics and clinical studies. Despite this, there is currently a lack in the development of open-source algorithms and tools for the analysis of DMET data. Existing software tools for DMET data generally allow only the preprocessing of binary data (e. g. the DMET-Console provided by Affymetrix) and simple data analysis operations, but do not allow to test the association of the presence of SNPs with the response to drugs. Results: We developed DMET-Analyzer a tool for the automatic association analysis among the variation of the patient genomes and the clinical conditions of patients, i.e. the different response to drugs. The proposed system allows: (i) to automatize the workflow of analysis of DMET-SNP data avoiding the use of multiple tools; (ii) the automatic annotation of DMET-SNP data and the search in existing databases of SNPs (e. g. dbSNP), (iii) the association of SNP with pathway through the search in PharmaGKB, a major knowledge base for pharmacogenomic studies. DMET-Analyzer has a simple graphical user interface that allows users (doctors/biologists) to upload and analyse DMET files produced by Affymetrix DMET-Console in an interactive way. The effectiveness and easy use of DMET Analyzer is demonstrated through different case studies regarding the analysis of clinical datasets produced in the University Hospital of Catanzaro, Italy. Conclusion: DMET Analyzer is a novel tool able to automatically analyse data produced by the DMET-platform in case-control association studies. Using such tool user may avoid wasting time in the manual execution of multiple statistical tests avoiding possible errors and reducing the amount of time needed for a whole experiment. Moreover annotations and the direct link to external databases may increase the biological knowledge extracted. The system is freely available for academic purposes at :https://sourceforge.net/projects/dmetanalyzer/files/
引用
收藏
页数:10
相关论文
共 50 条
  • [1] DMET-Analyzer: automatic analysis of Affymetrix DMET Data
    Pietro Hiram Guzzi
    Giuseppe Agapito
    Maria Teresa Di Martino
    Mariamena Arbitrio
    Pierfrancesco Tassone
    Pierosandro Tagliaferri
    Mario Cannataro
    [J]. BMC Bioinformatics, 13
  • [2] The Affymetrix DMET platform and pharmacogenetics in drug development
    Deeken, John
    [J]. CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2009, 11 (03) : 260 - 268
  • [3] Affymetrix DMET™ Plus Genotyping Technology: Evaluation of Cell Lines and Healthy Volunteer Samples
    Mills, Tracy
    Pilling, Mark
    Nicholls, Glynis
    Andersson, Tommy B.
    Bjorquist, Petter
    Aspegren, Anders
    Sartiby, Peter
    [J]. DRUG METABOLISM REVIEWS, 2010, 42 : 253 - 253
  • [4] A PHARMACOGENOMIC STUDY ON THE PHARMACOKINETICS OF TACROLIMUS IN HEALTHY VOLUNTEERS USING THE AFFYMETRIX DMET PLUS PLATFORM.
    Choi, Y.
    Jiang, F.
    Lee, H.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S29 - S29
  • [5] Micro-Analyzer: Automatic preprocessing of Affymetrix microarray data
    Guzzi, Pietro Hiram
    Cannataro, Mario
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2013, 111 (02) : 402 - 409
  • [6] The Affymetrix DMET Plus Platform Reveals Unique Distribution of ADME-Related Variants in Ethnic Arabs
    Wakil, SalmaM.
    Nguyen, Cao
    Muiya, Nzioka P.
    Andres, Editha
    Lykowska-Tarnowska, Agnieszka
    Baz, Batoul
    Tahir, Asma I.
    Meyer, Brian F.
    Morahan, Grant
    Dzimiri, Nduna
    [J]. DISEASE MARKERS, 2015, 2015
  • [7] Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform
    Kim, Byungwook
    Yoon, Deok Yong
    Lee, SeungHwan
    Jang, In-Jin
    Yu, Kyung-Sang
    Cho, Joo-Youn
    Oh, Jaeseong
    [J]. TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (03) : 135 - 149
  • [8] PGxClean: a quality control GUI for the Affymetrix DMET chip and other candidate gene studies with non-biallelic alleles
    Daniel Rotroff
    John Jack
    Nathan Campbell
    Scott Clark
    Alison A Motsinger-Reif
    [J]. BioData Mining, 7
  • [9] PGxClean: a quality control GUI for the Affymetrix DMET chip and other candidate gene studies with non-biallelic alleles
    Rotroff, Daniel
    Jack, John
    Campbell, Nathan
    Clark, Scott
    Motsinger-Reif, Alison A.
    [J]. BIODATA MINING, 2014, 7
  • [10] DMET-Miner: Efficient discovery of association rules from pharmacogenomic data
    Agapito, Giuseppe
    Guzzi, Pietro H.
    Cannataro, Mario
    [J]. JOURNAL OF BIOMEDICAL INFORMATICS, 2015, 56 : 273 - 283